Clinical Trial Update: Multi-Omics to Predict the Blood Pressure Response to Antihypertensives [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update from Radboud University Medical Center aims to use multi-omics approaches to predict how patients with essential hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Snippet

Sponsor: Radboud University Medical Center | Conditions: Primary Hypertension | Phase 4 | Status: RECRUITING